- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 8, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
A special report from Modern Healthcare on achieving transparency in healthcare highlighted a statistic from a study published in the February 2016 issue of The American Journal of Managed Care® (AJMC®). That study, titled “Characterizing Health Plan Price Estimator Tools: Findings From a National Survey,” found that just 45% of plans with cost-estimator tools used their negotiated rates with providers to calculate the estimate. Incorporating more complete data into transparency tools may increase their impact on consumers’ choices, the report stated.
MobiHealthNews published an article about health technology company AbleTo’s plans to use the $36.6 million in funding it has received from investors. The article referenced a study published in the February 2015 issue of AJMC® that demonstrated the platform’s ability to improve outcomes for health plan enrollees. “Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce Costs” presented encouraging findings, including lower hospitalizations, among Aetna members receiving the AbleTo intervention.
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
